$41.31
-0.39[-0.94%]
At close: Apr 16
$41.31
0[0.00%]
After Hours: 4:20PM EDT
Cerevel Therapeutics Hldg
(NASDAQ:CERE)Latest News for Cerevel Therapeutics Hldg Stock (NASDAQ:CERE)
Cerevel Therapeutics Hldg Stock (NASDAQ: CERE)
Categories: All
Monday, March 25, 2024
Friday, February 16, 2024
Tuesday, February 06, 2024
Friday, February 02, 2024
Monday, January 29, 2024
Monday, January 08, 2024
Friday, December 29, 2023
Thursday, December 28, 2023
Friday, December 22, 2023
Monday, December 11, 2023
Friday, December 08, 2023
Thursday, December 07, 2023
- AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst SignalsVandana Singh - Dec 7, 2023, 3:19PM
- HC Wainwright & Co. Downgrades Cerevel Therapeutics Hldg to Neutral, Raises Price Target to $45Benzinga Newsdesk - Dec 7, 2023, 2:33PM
- Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Dec 7, 2023, 1:13PM
- Why Cerevel Therapeutics Stock Is HigherErica Kollmann - Dec 7, 2023, 12:05PM
- Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On ThursdayAvi Kapoor - Dec 7, 2023, 10:17AM
- Cerevel Therapeutics shares are trading higher after AbbVie announced it will acquire the company for a total equity value of approximately $8.7 billion.Benzinga Newsdesk - Dec 7, 2023, 8:27AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Dec 7, 2023, 8:07AM
- Why Cerevel Therapeutics Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Dec 7, 2023, 7:59AM
- Datadog To Rally Over 22%? Here Are 10 Top Analyst Forecasts For ThursdayAvi Kapoor - Dec 7, 2023, 7:41AM
- Where Cerevel Therapeutics Hldg Stands With AnalystsBenzinga Insights - Dec 7, 2023, 7:00AM
- Piper Sandler Downgrades Cerevel Therapeutics Hldg to Neutral, Raises Price Target to $45Benzinga Newsdesk - Dec 7, 2023, 6:00AM
- Cantor Fitzgerald Downgrades Cerevel Therapeutics Hldg to Neutral, Raises Price Target to $45Benzinga Newsdesk - Dec 7, 2023, 5:50AM
Wednesday, December 06, 2023
- Why Cerevel Therapeutics Holdings Is Moving After-HoursRyan Gustafson - Dec 6, 2023, 5:14PM
- AbbVie Expects Proposed Cerevel Transaction To Be Accretive To Adjusted EPS Beginning In 2030Benzinga Newsdesk - Dec 6, 2023, 4:33PM
- Cerevel Therapeutics shares are trading higher after AbbVie announced it will acquire the company for a total equity value of approximately $8.7 billion.Benzinga Newsdesk - Dec 6, 2023, 4:32PM
- AbbVie To Acquire Cerevel Therapeutics; Transaction Valued At $45.00 Per Share In Cash, For Total Equity Value Of Approximately $8.7BBenzinga Newsdesk - Dec 6, 2023, 4:31PM
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga Insights - Dec 6, 2023, 4:31PM
- AbbVie Nears Roughly $8B For Drug Developer CerevelBenzinga Newsdesk - Dec 6, 2023, 4:04PM
Tuesday, December 05, 2023
Monday, November 20, 2023
Thursday, November 02, 2023
Wednesday, November 01, 2023
Thursday, October 19, 2023
Wednesday, October 18, 2023
Thursday, October 12, 2023
- Cerevel Therapeutics Holdings Files Prospectus Supplement Relates To Offering Of 19.7M Shares Of Co's Common StockBenzinga Newsdesk - Oct 12, 2023, 4:27PM
- Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Oct 12, 2023, 12:55PM
- Domino's, Walgreens, Fastenal And Other Big Stocks Moving Higher On ThursdayLisa Levin - Oct 12, 2023, 11:52AM
- Walgreens, Delta Air Lines And 3 Stocks To Watch Heading Into ThursdayLisa Levin - Oct 12, 2023, 3:59AM
- Cerevel Therapeutics Prices $450M Public Offering Of 19,728,189 Common Shares At $22.81/ShareBenzinga Newsdesk - Oct 12, 2023, 3:10AM